Agenda

Wednesday 10th December, 2008

08.30 Registration & Coffee

09.15 Chairperson's opening remarks

Allan Hong, Partner, China cGMP Group

Country & Industry Overview and Supplier Identification

09.30 Industry Overview: Pharma Sourcing from India and China - Past, Present and Future

• Exploring the current landscape of finished dose and API sourcing among innovators and generics
• Analysing the key advantages and challenges of operating in each market and the impact of the Olympics
• How do regulatory statistics and recent deals reflect these trends?
• How are these markets likely to develop in the future?

Mike Chace-Ortiz, Senior Director, Product Strategy (API Intelligence), Thomson Reuters Scientific

10.10 Successful supplier identification and auditing from emerging markets

• Effectively identifying and short listing new suppliers and understanding the cultural differences
• Benchmarking emerging market strategies to identify and audit new suppliers
• Achieving effective SRM by striking a mutual power balance with your new suppliers

Jan Ramakers, Sector Expert Pharmaceuticals & Fine Chemicals, CBI - Centre for Promotion of Imports from Developing Countries

10.50 The globalisation of innovation - capitalising on the growing R&D skills of India & China

• Identifying the most successful companies innovating and creating their own IP
• Tapping into the highest value segments of the global supply chain: advanced R&D
• Capitalising on the speed and quality of Phase I trials in India & China

Dr Sunita Vaidyanathan, Pharmaceuticals and Biotechnology Programme Manager, Frost & Sullivan

11.30 Refreshments & Networking Quality Assurances, Safety, IP, Supplier Auditing and Regulations

11.50 Comprehensively protecting against quality & safety risks when sourcing from India

• Developing robust auditing systems to vet and continually check your suppliers' suppliers
• How can you guarantee the quality of supply when 80-90% of raw materials are locally sourced?
• How to guarantee the quality of materials without setting up a local sourcing centre?

Alan Barnes, Head of Q & A, Dishman Europe

12.30  Ensuring Indian and Chinese suppliers comply with the regulatory environment

• Guaranteeing that suppliers and materials comply with EMEA and FDA standards
• Establishing effective risk mitigation processes to protect against potential supplier infringements
• Navigating the changing regulatory environment within China and India

Eileen Counihan, Director Commercialization & EMEA Compliance, Merck & Co

13.00 Successfully protecting IP when sourcing from and outsourcing to emerging markets

• Exploring the long-term view of IP - what will happen in 10-15 years?
• Successfully vetting new suppliers to protect again possible IP breaches
• Reviewing the range of measures available to protect IP when outsourcing to India & China

13.30 Lunch & Networking

Beyond Bottom Line Cost Savings

14.30 Looking beyond bottom line cost savings when sourcing from India

• Reviewing the indirect savings connected to marketing lead time and drug development
• Ensuring not only cost savings, but the quality of materials coming from India
• Exploiting the ability to scale up production when comparing India with the West

Marcel Velterop, Vice-President, Dr. Reddy's Laboratories

15.10 Panel Discussion:

China or India - Where to source from? A comparative panel discussion

• Is there a clear winner for specific materials and services?
• How have recent quality scares and decreasing board level confidence impacted on sourcing from china?
• Which country offers the biggest cost savings compared to the West and each other?
• Examining the potential internal markets for pharmaceuticals in India and China
• Are cultural and technical breakdowns in communication more prevalent in China or India?
• Does the hierarchical nature of privately held firms in India hinder sourcing strategies?

Chaired by: Allan Hong, Partner, China cGMP Group
Panel Members Include:
Alan Barnes, Head of Q & A, Dishman Europe   
Jan Ramakers, Sector Expert Pharmaceuticals & Fine Chemicals, CBI
Marcel Velterop, Vice-President, Dr. Reddy's Laboratories

15.50 Refreshments & Networking

16.10 Breakout Sessions: sourcing strategies for China & India:

Fine Chemicals
APIs
Contract Manufacturing
Contract Research

Each session with be led by an experienced sourcing practitioner. Groups will consist of  8-10 delegates.

Breakout sessions chairs include:

Dr Michael Bock, Head of Product Supply Latin & North America, Import & Export, Bayer HealthCare AG
Dr Patricia Lobo, Managing Partner, RSA
Dr Sunita Vaidyanathan, Pharmaceuticals and Biotechnology Programme Manager, Frost & Sullivan
Jan Ramakers, Sector Expert Pharmaceuticals & Fine Chemicals, CBI

17.00 Chairman's closing remarks

Allan Hong, Partner, China cGMP Group

17.10 Close of Conference